FDA panel recommends mRNA flu vaccine for older adults
The first flu shot of its kind is one step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for approval. The FDA’s independent vaccine advisers voted unanimously 9-0 that the benefits of Moderna’s amfluciva shot outweigh the risks in people…
